Stay updated on Tamibarotene Plus Azacitidine in RARA+ MDS Clinical Trial

Sign up to get notified when there's something new on the Tamibarotene Plus Azacitidine in RARA+ MDS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tamibarotene Plus Azacitidine in RARA+ MDS Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The new screenshot shows a revised layout and styling for the Record History page, with the same version history entries and study data as before. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-03T00:53:12.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    32 days ago
    Change Detected
    Summary
    Upgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.
    Difference
    9%
    Check dated 2025-10-05T08:35:45.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no substantive content changes detected.
    Difference
    0.2%
    Check dated 2025-09-28T03:03:05.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Revision upgraded from v3.0.1 to v3.0.2. The 'Back to Top' element was removed.
    Difference
    0.6%
    Check dated 2025-09-13T16:47:28.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.
    Difference
    0.6%
    Check dated 2025-09-06T14:18:27.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The web page has added a facility name and location details, which are crucial for identifying the context of the content. Additionally, numerous updates regarding study statuses and outcome measures have been included, reflecting ongoing research developments.
    Difference
    51%
    Check dated 2025-08-30T11:12:14.000Z thumbnail image

Stay in the know with updates to Tamibarotene Plus Azacitidine in RARA+ MDS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tamibarotene Plus Azacitidine in RARA+ MDS Clinical Trial page.